Loading...
Market
What action will Japan take in response to the mRNA vaccine study by December 31, 2024?
2
Resolution / Starting Odds
New regulations on mRNA vaccines • 25%
Public health advisory • 25%
No action taken • 25%
Further studies commissioned • 25%
Official government announcements or regulatory documents
Story
Japanese Scientists Link Covid mRNA-1273 Shots to Surge in Deadly Heart Failure in Youngsters
Jul 20, 2024, 04:09 PM
A group of Japanese scientists has used a specialized biopsy technique to prove that Covid mRNA shots are causing cases of deadly heart failure to surge globally. Dr. Hiroyuki Yamamoto from the Department of Cardiovascular Medicine at Narita-Tomisato Tokushukai Hospital led the research. The discovery was made using an endomyocardial biopsy (EMB) instead of the standard technique, which would easily miss this evidence. The findings have raised concerns about cardiac dysfunction in youngsters following the introduction of mRNA injections, including the mRNA-1273 third-dose. The study highlights the potential risks associated with Covid-19 vaccines, including inflammatory dilated cardiomyopathy, fatal myocarditis, and increased emergency cardiovascular events among the under-40 population in Israel during the vaccine rollout.
View original story
Similar markets
Yes • 50%
No • 50%
Less than 10 million • 25%
10-20 million • 25%
21-30 million • 25%
More than 30 million • 25%
Formal protest • 25%
Diplomatic talks • 25%
No action • 25%
Economic sanctions • 25%
Yes • 50%
No • 50%
No change in safety guidelines • 25%
Minor safety warning issued • 25%
Major safety warning issued • 25%
Vaccine approval revoked • 25%
Implement moratorium • 25%
Conduct further research • 25%
Ignore findings • 25%
Issue public warnings • 25%
No response • 25%
Denial of contamination claims • 25%
Acknowledgement of contamination and corrective measures • 25%
Legal action against claimants • 25%
Fast-tracked approval • 25%
Standard approval process • 25%
Request for more data • 25%
Rejection • 25%
Yes • 50%
No • 50%
Warning issued • 25%
Recall issued • 25%
Investigation initiated • 25%
No action taken • 25%
United States • 25%
United Kingdom • 25%
Canada • 25%
Other • 25%
Recall of early batches • 25%
Modification of production process • 25%
Increased monitoring/reporting • 25%
No significant action taken • 25%